サンバイオの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/02/28 | 2,811 | 2,823 | 2,716 | 2,721 | -94 | -3.3% | 1,552,700 |
2019/02/27 | 2,760 | 2,830 | 2,753 | 2,815 | +32 | +1.1% | 1,750,200 |
2019/02/26 | 2,821 | 2,864 | 2,757 | 2,783 | -48 | -1.7% | 2,257,900 |
2019/02/25 | 2,916 | 2,929 | 2,815 | 2,831 | -71 | -2.4% | 2,053,700 |
2019/02/22 | 2,990 | 3,040 | 2,875 | 2,902 | -158 | -5.2% | 4,977,700 |
2019/02/21 | 2,949 | 3,075 | 2,935 | 3,060 | +187 | +6.5% | 6,256,900 |
2019/02/20 | 2,850 | 2,930 | 2,819 | 2,873 | +73 | +2.6% | 4,683,800 |
2019/02/19 | 2,786 | 2,870 | 2,740 | 2,800 | +37 | +1.3% | 3,656,900 |
2019/02/18 | 2,768 | 2,883 | 2,746 | 2,763 | +33 | +1.2% | 5,269,500 |
2019/02/15 | 2,594 | 2,740 | 2,521 | 2,730 | +150 | +5.8% | 7,375,800 |
2019/02/14 | 2,895 | 2,948 | 2,550 | 2,580 | -273 | -9.6% | 7,665,200 |
2019/02/13 | 2,831 | 3,010 | 2,830 | 2,853 | -53 | -1.8% | 6,838,500 |
2019/02/12 | 3,320 | 3,340 | 2,881 | 2,906 | -249 | -7.9% | 9,081,700 |
2019/02/08 | 3,215 | 3,690 | 3,000 | 3,155 | -170 | -5.1% | 19,069,100 |
2019/02/07 | 3,135 | 3,325 | 3,100 | 3,325 | +504 | +17.9% | 13,140,000 |
2019/02/06 | 2,650 | 2,850 | 2,585 | 2,821 | +201 | +7.7% | 26,707,600 |
2019/02/05 | 2,440 | 2,880 | 2,401 | 2,620 | -1,090 | -29.4% | 53,568,200 |
2019/02/04 | 3,710 | 3,710 | 3,710 | 3,710 | -2,000 | -35% | 50,800 |
2019/02/01 | 5,710 | 5,710 | 5,710 | 5,710 | -1,500 | -20.8% | 10,500 |
2019/01/31 | 7,210 | 7,210 | 7,210 | 7,210 | -1,500 | -17.2% | 16,400 |
2019/01/30 | 8,710 | 8,710 | 8,710 | 8,710 | -3,000 | -25.6% | 21,100 |
2019/01/29 | 11,200 | 11,860 | 10,860 | 11,710 | +510 | +4.6% | 2,928,000 |
2019/01/28 | 11,400 | 11,480 | 11,160 | 11,200 | -250 | -2.2% | 994,900 |
2019/01/25 | 11,210 | 11,820 | 11,050 | 11,450 | +210 | +1.9% | 1,895,600 |
2019/01/24 | 11,610 | 11,740 | 11,030 | 11,240 | -180 | -1.6% | 1,736,400 |
2019/01/23 | 11,000 | 11,470 | 10,740 | 11,420 | +420 | +3.8% | 2,049,000 |
2019/01/22 | 11,110 | 11,480 | 10,620 | 11,000 | -210 | -1.9% | 2,740,900 |
2019/01/21 | 11,340 | 12,730 | 11,050 | 11,210 | +670 | +6.4% | 5,698,300 |
2019/01/18 | 10,470 | 10,920 | 10,400 | 10,540 | +90 | +0.9% | 1,809,700 |
2019/01/17 | 10,400 | 10,790 | 10,110 | 10,450 | +150 | +1.5% | 1,741,600 |
2019/01/16 | 10,410 | 10,440 | 10,010 | 10,300 | +50 | +0.5% | 1,049,100 |
2019/01/15 | 10,140 | 10,640 | 10,010 | 10,250 | +260 | +2.6% | 1,816,700 |
2019/01/11 | 10,370 | 10,500 | 9,890 | 9,990 | -190 | -1.9% | 1,839,400 |
2019/01/10 | 10,380 | 10,500 | 10,030 | 10,180 | -380 | -3.6% | 2,178,000 |
2019/01/09 | 9,950 | 10,720 | 9,780 | 10,560 | +860 | +8.9% | 3,679,200 |
2019/01/08 | 8,700 | 9,740 | 8,680 | 9,700 | +1,150 | +13.5% | 2,916,700 |
2019/01/07 | 8,670 | 8,870 | 8,370 | 8,550 | +180 | +2.2% | 1,293,400 |
2019/01/04 | 7,830 | 8,410 | 7,770 | 8,370 | +260 | +3.2% | 998,000 |
2018/12/28 | 8,670 | 8,800 | 8,050 | 8,110 | -590 | -6.8% | 1,481,900 |
2018/12/27 | 8,760 | 8,920 | 8,450 | 8,700 | +640 | +7.9% | 1,443,100 |
2018/12/26 | 8,140 | 8,430 | 7,820 | 8,060 | +340 | +4.4% | 1,383,900 |
2018/12/25 | 7,680 | 7,900 | 7,340 | 7,720 | -560 | -6.8% | 1,729,700 |
2018/12/21 | 8,380 | 8,520 | 7,930 | 8,280 | -270 | -3.2% | 1,439,900 |
2018/12/20 | 9,230 | 9,350 | 8,400 | 8,550 | -830 | -8.8% | 2,110,600 |
2018/12/19 | 8,700 | 9,630 | 8,340 | 9,380 | +770 | +8.9% | 2,005,700 |
2018/12/18 | 8,110 | 8,780 | 8,050 | 8,610 | +210 | +2.5% | 1,048,600 |
2018/12/17 | 8,880 | 8,900 | 8,290 | 8,400 | -430 | -4.9% | 876,400 |
2018/12/14 | 8,850 | 9,010 | 8,320 | 8,830 | +130 | +1.5% | 920,700 |
2018/12/13 | 9,050 | 9,250 | 8,620 | 8,700 | -250 | -2.8% | 918,400 |
2018/12/12 | 8,130 | 9,100 | 8,080 | 8,950 | +870 | +10.8% | 1,083,000 |
1401~
1450
件表示中 / 2354件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
JCRファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
あすかHD | 203,600円 | +0.3% | +2.7% | 2.46% | 11.55倍 | 0.90倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
タウンズ | 56,300円 | +4.6% | +6.1% | 4.97% | 9.46倍 | 4.17倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症得意 |
市場注目の銘柄
チャート関連のコラム